Publicly available gene expression data [22] (www.oncomine.org) were analyzed for the expression and prognostic relevance of EGFR and AURORA-A expression. AURORA-A transcripts were expressed at significantly higher levels in SCCHN tumor samples as compared to normal control tissue (p = 0.002, Figure 1), and the median relative expression in surviving patients was lower as compared to patients dying from SCCHN (n.s.). This evidence concerns the gene EGFR and neoplasm.